Article

FFB funds nearly $3 million to research

Almost $3 million has been invested in nine research projects aimed at saving and restoring sight by the Foundation Fight Blindness.

 

Columbia, MD-Almost $3 million has been invested in nine research projects aimed at saving and restoring sight by the Foundation Fighting Blindness.

The foundation’s Scientific Advisory Board completed its annual grants review process, leading to the allocation of seven new $300,000, three-year grants which total $2.1 million.

The grants will focus on developing cross-cutting gene therapies, identifying new disease-causing gene mutations, and advancing potential treatments for dry age-related macular degeration.

Another $800,000 was awarded to two research efforts at the University of California, Berkley, which focus on optogenetic approaches to treat blinding inherited retinal diseases.

“Retinal diseases together affect more than 10 million Americans, and with an aging population, this number is growing,” said Stephen Rose, PhD, the foundation’s chief research officer. “The progress being made in research right now is remarkable; however, there is still a long way to go to secure the resources to significantly expand the portfolio of trials across the spectrum of retinal diseases.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.